Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.
Don't know the stock symbol? Use the
Symbol Lookup tool.
Alphabetize the sort order of my symbols
Investing just got easier…
Sign up now to become a NASDAQ.com member and begin receiving instant notifications when key events occur that affect the stocks you follow.Access Now
Key Stock Data
The current last sale of $3.31 is 289.41% Higher than the 52 week low.
|Intraday||Last 52 Weeks|
|High:||$ 3.52||$ 5.70|
|Low:||$ 3.29||$ 0.85|
Company Description (as filed with the SEC)
Oasmia Pharmaceutical AB is a pharmaceutical company which develops, manufactures, markets and sells a new generation of drugs within human and veterinary oncology. The product development aims to manufacture novel formulations based on well-established cytostatic which, in comparison with current alternatives, show improved properties, a reduced side-effect profile and an expanded therapeutic area. The product development is based on in-house research within nanotechnology and company patents. The Company's shares are listed on NASDAQ Stockholm and the NASDAQ Capital Markets. We are a Swedish public company. Our principal executive offices are located in Uppsala, Sweden. Company information Company name: OASMIA PHARMACEUTICAL AB Address: Vallongatan 1, 752 28 Uppsala, Sweden Contact information: +46 18 50 54 40 Fax: +46 18 51 08 73 Email address: email@example.com Website: www.oasmia.com B. Business overview. ... More ...
Nasdaq Official Price
Dec. 18, 2018
Dec. 18, 2018